biOasis Technologies Ord Shs V.BTI.H

Primary Symbol: BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by neinsteinon May 06, 2014 10:13pm

148 Views

Post# 22531722

RE:RE:RE:RE:RE:RE:nice to see

tell you what oilpatch. post a photo of your trade confirms. both the buy(s) and the sell(s). if they the math adds up (yes sorry there is math involved) to match your ill timed posts we'll accept your great success in timing that disaster of a stock.

otherwise shut up. you lost money. we find it extremely funny.

Bullboard Posts

The top 5 Canadian small-cap AI stocks